Mary Allen

7PUBLICATIONS
72CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsInnate immunityPacific Peoples health promotion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 30, 2025
Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial.

K Rachael Parks, Zoe Moodie, Mary A Allen

|Apr 28, 2025
High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302).

Sharon A Riddler, Zoe Moodie, Jesse Clark

|May 23, 2020
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.

Zoe Moodie, Stephen R Walsh, Fatima Laher

|Feb 25, 2020
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.

Fatima Laher, Zoe Moodie, Kristen W Cohen

|Nov 22, 2019
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial.

Esper G Kallas, Nicole A Grunenberg, Chenchen Yu

|Sep 21, 2018
Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.

Marnie L Elizaga, Shuying S Li, Nidhi K Kochar

Pageof 2

Frequent Collaborators

4 joint publications

Zoe Moodie

4 joint publications

David Montefiori

4 joint publications

M Juliana McElrath

4 joint publications

Nicole Grunenberg